CBD Conditions - Digestive Issues

Digestive issues affect over 70 million people every day. It covers a variety of health problems, such as colitis, Crohn’s disease, and irritable bowel disease. These conditions severely affect people’s quality of life because of issues with their digestive systems. Anybody is susceptible to these diseases.

Colitis and Crohn’s

  1. CBD in inflammatory bowel diseases: a brief overview
  2. Cannabis finds its way into treatment of Crohn’s disease
  3. CBD reduces intestinal inflammation through the control of neuroimmune axis
  4. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
  5. The effects of Delta-tetrahydrocannabinol and CBD alone and in combination on damage, inflammation and in vitro motility disturbances in rat coliti
  6. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
  7. Cannabinoids and the gut: New developments and emerging concepts
  8. Endocannabinoids and the gastrointestinal tract
  9. Cannabinoids and gastrointestinal motility: Animal and human studies
  10. Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis
  11. Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review
  12. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial.

Irritable Bowel Syndrome

  1. Cannabidiol in inflammatory bowel diseases: A brief overview
  2. CBD reduces intestinal inflammation through the control of neuroimmune axis
  3. Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
  4. Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
  5. Therapeutic potential of cannabinoid-based drugs
  6. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)
  7. CBD and the gut: New developments and emerging concepts
  8. Endocannabinoids and the gastrointestinal tract
  9. CBD and gastrointestinal motility
  10. Getting into the weed: the role of the endocannabinoid system in the brain-gut axis